Protein Science 2011-04-01

Structure analysis reveals the flexibility of the ADAMTS-5 active site.

Huey-Sheng Shieh, Alfredo G Tomasselli, Karl J Mathis, Mark E Schnute, Scott S Woodard, Nicole Caspers, Jennifer M Williams, James R Kiefer, Grace Munie, Arthur Wittwer, Anne-Marie Malfait, Micky D Tortorella

Index: Protein Sci. 20(4) , 735-44, (2011)

Full Text: HTML

Abstract

A ((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl) succinamide derivative (here referred to as Compound 12) shows significant activity toward many matrix metalloproteinases (MMPs), including MMP-2, MMP-8, MMP-9, and MMP-13. Modeling studies had predicted that this compound would not bind to ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs-5) due to its shallow S1' pocket. However, inhibition analysis revealed it to be a nanomolar inhibitor of both ADAMTS-4 and -5. The observed inconsistency was explained by analysis of crystallographic structures, which showed that Compound 12 in complex with the catalytic domain of ADAMTS-5 (cataTS5) exhibits an unusual conformation in the S1' pocket of the protein. This first demonstration that cataTS5 can undergo an induced conformational change in its active site pocket by a molecule like Compound 12 should enable the design of new aggrecanase inhibitors with better potency and selectivity profiles.Copyright © 2011 The Protein Society.

Related Compounds

  • Butanediamide

Related Articles:

Effects of structural analogues of the substrate and allosteric regulator of the human mitochondrial NAD(P)+-dependent malic enzyme.

2009-08-01

[Bioorg. Med. Chem. 17 , 5414-9, (2009)]

Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core.

2004-01-19

[Bioorg. Med. Chem. Lett. 14 , 377, (2004)]

A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model.

2004-08-03

[Biochemistry 43(30) , 9866-76, (2004)]

Adaptable synthesis of C-glycosidic multivalent carbohydrates and succinamide-linked derivatization.

2010-11-19

[Org. Lett. 12(22) , 5262-5, (2010)]

Synthesis of novel succinamide derivatives having the 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. I.

1997-06-01

[Chem. Pharm. Bull. 45(6) , 996-1007, (1997)]

More Articles...